Skip to content
Open in App
Dexcom logo

Dexcom

web2

DexCom, Inc., a medical device company, focuses on the design, development, and commercializati...

Symbol · 1DXCM
Company profile

About

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

Explore by sector

Explore this sector

Market identity

Exchange listings

Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.

Progress

Roadmap

Dexcom selected as first FDA TEMPO pilot participant

KEY STEP

The FDA selected Dexcom as the first participant in the TEMPO digital health devices pilot. Dexcom’s Glucose Health Program will be evaluated for uses that include metabolic monitoring and screening support for prediabetes and Type 2 diabetes in connection with the CMS ACCESS model.

Roadmap reference
People

Company team

BP

Bridgette P. Heller

Independent Director

Company leadership profile.

EA

Euan Angus Ashley

Independent Director

Company leadership profile.

KR

Kevin Ronald Sayer

Executive Chairman of the Board

Company leadership profile.

JS

Jacob Steven Leach

President, CEO & Director

Company leadership profile.

NA

Nicholas Augustinos

Independent Director

Company leadership profile.

MG

Mark G. Foletta

Lead Independent Director

Company leadership profile.

SR

Steven R. Altman

Independent Director

Company leadership profile.

RA

Richard A. Collins

Independent Director

Company leadership profile.

KM

Kyle Malady

Independent Director

Company leadership profile.

RD

Rimma Driscoll

Independent Director

Company leadership profile.

RD

Renee D. Gala

Independent Director

Company leadership profile.

AF

Albert Frederic Osterloh

Independent Director

Company leadership profile.

Expert coverage

1 expert evaluated Dexcom.

Orbitrum research

Experts evaluating Dexcom

Explore the public profiles of experts who have evaluated this project.

Orbitrum Academy

Learn how to read a project assessment